PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2024 Earnings Call Transcript
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2024 Earnings Call Transcript October 28, 2024PROCEPT BioRobotics Corporation beats earnings expectations.
Procept Biorobotics Corp (PRCT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 463,380 | $37,126,006 | +68% | 0.03% |
| 2. | Rhenman & Partners Asset Management Henrik Rhenman | 445,000 | $35,653,400 | +2% | 2.89% |
| 3. | Driehaus Capital Richard Driehaus | 352,021 | $28,203,923 | +1% | 0.24% |
| 4. | Perceptive Advisors Joseph Edelman | 315,659 | $25,290,599 | +50% | 0.53% |
| 5. | Osterweis Capital Management John Osterweis | 136,315 | $10,921,558 | -21% | 0.55% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.43 | 940 | Director | 147,713 | 2022-03-11 | Filing | |
| $25.00 | 3,200 | Director | 3,200 | 2021-09-17 | Filing | |
| $25.00 | 440,000 | Large Shareholder, Director | 11,222,662 | 2021-09-17 | Filing | |
| $25.00 | 10,000 | Director | 45,074 | 2021-09-17 | Filing | |
| $25.00 | 6,800 | Director | 6,800 | 2021-09-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $95.58 | 4,510 | Officer, Director | 232,025 | 2024-11-13 | Filing | |
| $94.95 | 9,401 | Officer, Director | 236,535 | 2024-11-13 | Filing | |
| $93.64 | 2,000 | Officer, Director | 245,936 | 2024-11-13 | Filing | |
| $92.74 | 10,509 | Officer, Director | 247,936 | 2024-11-13 | Filing | |
| $97.54 | 500 | Director | 164,363 | 2024-11-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,361,844 | $308,534,882 | 0.02% | |
| 2. | 5,328,867 | $223,332,816 | 97.25% | |
| 3. | 4,184,585 | $175,375,958 | 0% | |
| 4. | 3,357,638 | $140,718,607 | 0% | |
| 5. | 2,056,350 | $86,181,629 | 0.03% |
News See All
20 Hidden Gem AI Stocks
The rise of artificial intelligence (AI) businesses has loomed large over finance markets in the past few months, pushing investor attention away from other topics.
10 Worst AI Stocks to Buy According to Reddit
In the lead-up to the September rate cut decision, analysts had expressed a variety of opinions regarding the 50 basis-point cut, with some supporting and others opposing it.
10 Worst Small Cap AI Stocks To Buy According to Short Sellers
Analysts have been anticipating interest rate cuts for a while now, with bets on either a 25- or a 50-basis point reduction.
Do You Believe in the Growth Prospects of PROCEPT BioRobotics (PRCT)?
Next Century Growth Investors, LLC, an investment Management Company, released its “Small Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q2 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to PROCEPT BioRobotics Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call Transcript
PROCEPT BioRobotics Corporation beats earnings expectations. Reported EPS is $-0.51, expectations were $-0.55.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q4 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Q4 2023 PROCEPT BioRobotics Earnings Conference Call. At this time, all participants are in a listen-only mode.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2023 Earnings Call Transcript
Operator: Good day and welcome to PROCEPT BioRobotics Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to PROCEPT BioRobotics Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
Billionaire Hedge Funds
